A clinician's desk with a stethoscope and an open medical chart

If you are a neurosurgeon, neurologist, nurse practitioner, physician assistant, neuropsychologist, psychiatrist, primary care provider, nurse, social worker, or therapist involved in the care of patients after brain surgery, this section provides an evidence-informed framework you can integrate into your practice. Every intervention is rated using a transparent evidence-tier system, and the underlying research is cited throughout.

This framework emerged from direct clinical observation: patients leaving neurosurgical clinics with clean imaging and persistent suffering — identity disruption, emotional dysregulation, grief, cognitive fatigue, and a pervasive sense that something fundamental had changed. The literature confirms what clinicians see: 30–70% of neurosurgery patients experience significant emotional or personality changes, and 40–60% of these go undetected by standard screening.

The Gap This Section Addresses

Most neurosurgical follow-up focuses on three questions: Is the pathology resolved? Are there complications? Is the patient neurologically stable? These are necessary questions. They are not sufficient.

The gap is emotional recovery. Patients leave our clinics with clean MRIs and persistent suffering. They often cannot articulate what is wrong, and we often do not ask. When we do ask, the standard tools — the PHQ-9, the GAD-7 — were not designed to detect the specific emotional changes that follow neurosurgery: identity disruption, emotional blunting, personality shifts, grief for a former self.

Research confirms the scope. Jenkins and colleagues found that emotional and behavioral changes following brain tumor surgery are common, clinically relevant, and often more visible to caregivers than to patients themselves. Zamanipoor Najafabadi and colleagues followed meningioma patients for up to nine years and found psychosocial deficits that standard follow-up protocols consistently missed. The pattern is clear: we are technically excellent at the surgery and systematically inadequate at addressing what comes after.

Evidence Tier System

Vintage medical illustration of neural pathways and synapses

All interventions discussed on this site and in the book are rated using a four-tier evidence system. The goal is transparency: patients and clinicians can see exactly how strong the evidence is for any recommendation.

Tier 1 — Strong Evidence: Supported by randomized controlled trials, systematic reviews, or meta-analyses. Broadly accepted in clinical practice.
Tier 2 — Moderate Evidence: Supported by observational studies, case series, or consistent clinical experience. Reasonable to recommend with appropriate disclosure.
Tier 3 — Emerging Evidence: Supported by preliminary research, animal models, or expert consensus. Promising but not yet definitive. Presented as emerging, not established.
Tier 4 — Experiential: Widely reported by patients but not yet formally studied in post-surgical populations. Included for completeness with clear labeling.

This tiering system respects both the clinician's need for evidence and the patient's need for options. Patients who present supplement or device questions are not seeking alternative medicine — they are seeking adjunctive support with clinical plausibility. Your engagement with their questions, even brief engagement, validates their recovery agency and strengthens the therapeutic alliance.

Implement Screening in Your Practice

The Post-Craniotomy Recovery Experience Scale (PCRES) is a free, open-access, 35-item patient-reported outcome measure designed specifically for this population. It captures identity disruption, neurofatigue, grief, and the medical-experience gap that standard instruments miss. Online assessment, instant scoring, clinical flags, and full provider setup documentation are available at pcres.org.